Adaptive Biotechnologies Corp (ADPT) Financial Statements (2026 and earlier)

Company Profile

Business Address 1165 EASTLAKE AVE E
SEATTLE, WA 98109
State of Incorp. WA
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments226,980222,294346,401498,196353,061688,269
Cash and cash equivalent70,49547,92065,06490,030139,065123,436
Short-term investments156,485174,374281,337408,166213,996564,833
Receivables50,36541,73137,96940,05717,60910,947
Inventory, net of allowances, customer advances and progress billings9,8208,44014,44814,45319,26314,063
Inventory9,8208,44014,44814,45319,26314,063
Other undisclosed current assets13,02011,28711,3709,44012,81513,635
Total current assets:300,185283,752410,188562,146402,748726,914
Noncurrent Assets
Operating lease, right-of-use asset40,61645,76752,09680,76387,67899,350
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization34,10748,61668,22783,44785,26239,692
Long-term investments and receivables13,23433,660  217,145118,525
Long-term investments13,23433,660  217,145118,525
Intangible asset, including goodwill, after accumulated amortization120,698122,397124,100125,799127,498129,197
Goodwill118,972118,972118,972118,972118,972118,972
Intangible asset, excluding goodwill, after accumulated amortization1,7263,4255,1286,8278,52610,225
Restricted cash and investments2,6892,8972,9322,3982,1382,138
Other noncurrent assets1,2072,2873,5912,064875598
Total noncurrent assets:212,551255,624250,946294,471520,596389,500
TOTAL ASSETS:512,736539,376661,134856,617923,3441,116,414
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities14,16715,42216,31620,50828,29228,349
Employee-related liabilities✕✕✕✕✕15,64211,950
Accounts payable6,4677,2657,7198,0843,3073,237
Accrued liabilities7,7008,1578,59712,4249,34313,162
Deferred revenue45,19455,68948,63064,11580,46073,319
Debt4,642865    
Other undisclosed current liabilities25,91226,07723,06925,1655,0553,529
Total current liabilities:89,91598,05388,015109,788113,807105,197
Noncurrent Liabilities
Long-term debt and lease obligation126,566132,414130,660 106,685104,333
Long-term debt, excluding current maturities126,566132,414130,660   
Liabilities, other than long-term debt71,254106,424134,181157,37198,750163,618
Deferred revenue1,00627,25644,79358,59998,750163,618
Other liabilities2020    
Operating lease, liability70,22879,14889,38898,772106,685104,333
Other undisclosed noncurrent liabilities    125,360  
Total noncurrent liabilities:197,820238,838264,841282,731205,435267,951
Total liabilities:287,735336,891352,856392,519319,242373,148
Equity
Equity, attributable to parent218,793202,709308,399464,165603,992743,266
Common stock151414141414
Additional paid in capital1,581,8481,506,3531,452,5021,387,3491,324,0061,253,971
Accumulated other comprehensive income (loss)253166215(4,116)(1,137)893
Accumulated deficit(1,363,323)(1,303,824)(1,144,332)(919,082)(718,891)(511,612)
Equity, attributable to noncontrolling interest6,208(224)(121)(67)110 
Total equity:225,001202,485308,278464,098604,102743,266
TOTAL LIABILITIES AND EQUITY:512,736539,376661,134856,617923,3441,116,414

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues276,976178,957170,276185,308154,34498,382
Cost of revenue(73,058)(80,988)(75,582)(57,909)(49,301)(22,530)
Cost of product and service sold(71,359)(72,080)(75,553)(57,909)(49,301)(22,530)
Gross profit:203,91897,96994,694127,399105,04375,852
Operating expenses(261,041)(260,518)(321,729)(327,585)(314,009)(228,669)
Operating loss:(57,123)(162,549)(227,035)(200,186)(208,966)(152,817)
Interest and debt expense   (13,800)(4,238)  
Loss from continuing operations before equity method investments, income taxes:(57,123)(162,549)(240,835)(204,424)(208,966)(152,817)
Other undisclosed income (loss) from continuing operations before income taxes(2,334)2,95415,5314,0561,668 
Loss from continuing operations:(59,457)(159,595)(225,304)(200,368)(207,298)(152,817)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(207,298)(152,817)
Other undisclosed net income (loss)     6,590
Net loss:(59,457)(159,595)(225,304)(200,368)(207,298)(146,227)
Net income (loss) attributable to noncontrolling interest(42)1035417719 
Net loss available to common stockholders, diluted:(59,499)(159,492)(225,250)(200,191)(207,279)(146,227)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(59,457)(159,595)(225,304)(200,368)(207,298)(146,227)
Other undisclosed comprehensive income (loss)87(49)4,331(2,979)(2,030) 
Comprehensive loss:(59,370)(159,644)(220,973)(203,347)(209,328)(146,227)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(42)1035417719 
Other undisclosed comprehensive income, net of tax, attributable to parent      222
Comprehensive loss, net of tax, attributable to parent:(59,412)(159,541)(220,919)(203,170)(209,309)(146,005)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: